68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.

Wang J, Jia Y, Xiang J, Lin K, Wang R, Wang Y, Chen J, Luo Y, Fei Y, Zhu Z

Open source

DOI
10.1093/rheumatology/keag440
Published
2026 Sep 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/keag440,
  title = {68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.},
  author = {Wang J and Jia Y and Xiang J and Lin K and Wang R and Wang Y and Chen J and Luo Y and Fei Y and Zhu Z},
  year = {2026},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/keag440},
  url = {https://doi.org/10.1093/rheumatology/keag440}
}

RIS

TY  - JOUR
TI  - 68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.
AU  - Wang J
AU  - Jia Y
AU  - Xiang J
AU  - Lin K
AU  - Wang R
AU  - Wang Y
AU  - Chen J
AU  - Luo Y
AU  - Fei Y
AU  - Zhu Z
PY  - 2026
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/keag440
UR  - https://doi.org/10.1093/rheumatology/keag440
ER  - 

APA

J, W., Y, J., J, X., K, L., R, W., Y, W., J, C., Y, L., Y, F., & Z, Z. (2026). 68Ga-FAPI PET/CT for assessing fibroblast activation and disease activity in primary Sjögren's disease: a prospective case-control study.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keag440

Source records